SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

SVB Leerink Maintains Market Perform on Satsuma Pharmaceuticals, Raises Price Target to $5

SVB Leerink analyst Marc Goodman maintains Satsuma Pharmaceuticals (NASDAQ:STSA) with a Market Perform and raises the price target from $4 to $5.

05/12/2021 06:18
SVB Leerink analyst Marc Goodman maintains Satsuma Pharmaceuticals (NASDAQ:STSA) with a Market Perform and raises the price target from $4 to $5.